![Alan Bash](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Bash
Corporate Officer/Principal bei
LEGEND BIOTECH CORPORATION
Vermögen: 178 105 $ am 31.08.2026
Profil
Mr. Alan S.
Bash is a President-Carvykti at Legend Biotech Corp.
Mr. Bash was previously employed as a Chief Executive Officer & Director by ZielBio, Inc., a President & Chief Executive Officer by Checkmate Pharmaceuticals, Inc., and a Senior Vice President-Commercial Model Innovation by Bristol Myers Squibb Co. He received his undergraduate degree from Georgetown University and an MBA from Columbia Business School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0.01% | 14.08.2026 | 17’142 ( 0.01% ) | 178 105 $ | 31.08.2026 |
Aktive Positionen von Alan Bash
| Unternehmen | Position | Beginn |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Corporate Officer/Principal | 15.09.2026 |
Ehemalige bekannte Positionen von Alan Bash
| Unternehmen | Position | Ende |
|---|---|---|
ZielBio, Inc.
 ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Vorstandsvorsitzender | 01.10.2024 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| CHECKMATE PHARMACEUTICALS, INC. | Vorstandsvorsitzender | - |
Ausbildung von Alan Bash
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
26
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
ZielBio, Inc.
ZielBio, Inc. Medical SpecialtiesHealth Technology Develops a technology for identification of cancerous diseases | Health Technology |
Georgetown University
 Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Legend Biotech Corp.
 Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
